Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy.
about
Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis18F-fluorodeoxyglucose uptake predicts PKM2 expression in lung adenocarcinomaPyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis.Linking vitamin B1 with cancer cell metabolismProspective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma.Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancerDiagnostic utility of faecal biomarkers in patients with irritable bowel syndromeCancer stem cells, microRNAs, and therapeutic strategies including natural products.Biomarkers in the diagnosis and early detection of pancreatic cancer.Blood-based peptide, genetic, and epigenetic biomarkers for diagnosing gastrointestinal cancers.Glucose metabolic phenotype of pancreatic cancer.Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer.Novel signatures of cancer-associated fibroblasts.Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma.Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients.A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells.Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.Lapatinib Inhibits Breast Cancer Cell Proliferation by Influencing PKM2 Expression.Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.How close are we to finding noninvasive markers for upper GI tract cancer?PKM2 released by neutrophils at wound site facilitates early wound healing by promoting angiogenesis.Knockdown of PKM2 suppresses tumor progression in human cervical cancer by modulating epithelial-mesenchymal transition via Wnt/β-catenin signaling
P2860
Q24616985-B11570FD-7B3D-4578-B57C-8BD948E2AB4FQ33889303-4D204495-4464-49E6-9B1E-148989AA42D7Q34170794-753B79A3-FAFD-468B-ADB9-DF9175C976B8Q34258898-1393795B-9923-4C3D-B19E-8800854F2755Q35544474-B039DED6-7201-44A8-8B06-DEDB60C30E36Q35604069-76C50FA1-6C86-45CF-8746-73F413BC3927Q36247437-0D15389B-F949-4E1C-B1EF-991C42F251DAQ36381459-0669C7F3-EC7C-4036-B88E-8C6B313E1C7BQ37581340-341FE828-5CBA-4C77-AEF7-AF57B1C77F44Q38023238-5F4CA82E-F9A7-4DB5-82A8-D43DAB7277C4Q38089821-0F6185CA-53E9-49FF-A2FC-6477687CB058Q38089897-31788428-DB61-4695-8394-54CC500AF6BAQ38791962-655C4C1D-8AC6-406C-95B2-F538A47EE5BAQ38931288-2828333D-6DD7-443C-9179-941C5D043137Q39210456-F8F8495D-0AA8-48C2-9CB9-A19B26EC73D0Q39773538-6B258C5F-6ADF-461B-9916-F33897C9A5CDQ40026559-5690F7AB-E993-4F34-A952-83ACAE6C1FC3Q41345834-D50D6641-437F-4742-A8A2-81A6747606E4Q44176691-44F21CBE-4269-4827-B1E1-FD09B5BD6AAAQ45354033-849F66B9-A83A-49F4-A671-AAFCA5073E14Q47094355-A923F878-29B8-4C93-923A-4D583CB4F4F9Q49993915-E96E35C8-E04B-48AD-A0F0-CF0188046B78Q51210845-64E7F51C-1EC9-40A4-91CF-9C27D5F1A4D7Q51671468-319DB27F-E02A-4D9C-9293-5ECCB35427CDQ54978039-9A2B375C-1295-434B-8D4E-0992B470B109Q57483486-9885ACB9-6B27-4D6C-B2C6-E6ABDD5CF3E4
P2860
Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Current status of tumor M2 pyr ...... f gastrointestinal malignancy.
@en
type
label
Current status of tumor M2 pyr ...... f gastrointestinal malignancy.
@en
prefLabel
Current status of tumor M2 pyr ...... f gastrointestinal malignancy.
@en
P2860
P1476
Current status of tumor M2 pyr ...... f gastrointestinal malignancy.
@en
P2093
Harsha R Hathurusinghe
Kolitha S Goonetilleke
P2860
P2888
P304
P356
10.1245/S10434-007-9481-X
P577
2007-06-30T00:00:00Z
P5875
P6179
1034978521